摘要
目的:探讨伽玛刀放射外科治疗颅咽管瘤的临床效果和预后。方法:回顾性分析49例颅咽管瘤患者的临床资料,均给予伽玛刀放射外科治疗,肿瘤平均体积为2.75 cm^3,边缘平均剂量为11.8 Gy。临床效果通过磁共振检查、神经内分泌学和下丘脑症状、并发症和KPS评分评价。结果:49例患者影像学检查,16例完全缓解,20例部分缓解,9例无变化,4例肿瘤进展。肿瘤反应率为69.4%,控制率为87.8%。使用11.8 Gy的边缘剂量治疗较小的颅咽管瘤,有更好的控制率且没有并发症发生。KPS评分100分24例, 90分16例,70~80分4例,50~60分2例。Kaplan-Meier生存分析表明5年生存率为95.9%,10年生存率为87.8%。5年肿瘤无进展生存率为77.6%,10年肿瘤无进展生存率为73.5%。3例患者因肿瘤进展死亡。结论:在显微手术联合放射治疗后,肿瘤体积的减小和有效的放射剂量设定对于改善患者生活质量和生存至关重要。
Objective:To evaluate outcome and prognosis of craniopharyngioma treated by Gamma knife radiosurgery.Methods:Clinical data of 49 cases of craniopharyngioma were analyzed retrospectively,which were all treated by Gamma knife radiosurgery.The mean volume of craniopharyngioma was 2.75 cm^3 and the mean marginal dose was 11.8 Gy.The outcomes were assessed by MRI,neuro-endocrine and hypothalamic symptoms,coaplications and KPS scores.Results:Complete remission was in 16,partial remission was in 20,no change in 9 and progression in 4 patients.Tumor response was 69.4%and tumor control rate was 87.8%.Marginal dose of 11.8 Gy was used to a smaller tumor and better control rate without complications was obtained.KPS was excellent in 24,good in 16,fair in 4 and poor in 2.Kaplan-Meier curves showed 5-year survival rate was 95.9%and 10-year survival rate was 87.8%.Progression-free survival was 77.6%at 5 years and 73.5%at 10 years,respectively.Three cases died of tumor progression.Conclusion:Reduction of tumor volume and effective dose setting will be important for the improvement of quality of life and survival after microsurgery combined with radiosurgery of craniopharyngioma.
作者
薛亚飞
邬迎喜
赵兰夫
吕文海
赵天智
贺世明
Xue Yafei;Wu Yingxi;Zhao Lanfu;Lv Wenhai;Zhao Tianzhi;He Shiming(Department of Neurosurgery,Tangdu Hospital of the Air Force Medical University,Shaanxi Xi'an 710038,China)
出处
《现代肿瘤医学》
CAS
2019年第10期1721-1724,共4页
Journal of Modern Oncology
关键词
颅咽管瘤
伽玛刀放射外科
肿瘤复发
放疗剂量
craniopharyngioma
Gamma knife radiosurgery
tumor recurrence
radiotherapy dose